Navigation Links
Baxa Corporation Features PadLock(R) Set Saver at the ANCC National Magnet Conference(TM)
Date:10/15/2008

Baxa is promoting its new PadLock Set Saver product at the American Nursing Credentialing Center National Magnet Conference in Salt Lake City, UT, at The Salt Palace, October 15-17, 2008.

ENGLEWOOD, Colo., Oct. 15 /PRNewswire/ -- Baxa Corporation is promoting its new PadLock Set Saver at the ANCC National Magnet Conference, October 15-17, in Salt Lake City. An aseptic IV administration set storage solution, PadLock provides a secure seal for the end of the administration set, preventing contamination when the set is not being used for infusion. Effective for multiple uses, the Set Saver attaches to an IV administration set and replaces the need for sterile, single-use caps. During the three-day exhibition, the Baxa sales team will demonstrate the new device at booth #613.

The ANCC, which sponsors the national conference, is the world's largest and most prestigious nurse credentialing organization and gives exposure through this venue to more than 5500 highly qualified nurses. This conference supports excellence in nursing and promotes quality patient care. The innovative PadLock Set Saver is designed to foster best practice for aseptic IV administration set maintenance, preventing touch contamination and securing the IV line between drug administrations.

Baxa Corporation is a world leader in developing innovative technology for the safe handling, packaging and administration of fluid medications in hospital and alternate-care settings. Renowned for enhancing patient safety and improving processes within pharmacy settings. The PadLock Set Saver allows Baxa to bring its expertise and experience to the patient bedside.

About Magnet

The Magnet Recognition Program(R) was developed by the American Nurses Credentialing Center (ANCC) to recognize healthcare organizations that provide exceptional nursing care and uphold the tenets of professional nursing practice. Only 4% of U.S. hospitals have Magnet status. It is truly the "gold standard" for excellence in nursing. The program also provides a vehicle for disseminating best practices and successful strategies among healthcare organizations. Currently there are 265 Magnet organizations with hundreds more in the applications process. Regardless of a healthcare organizations size, setting, or location, achieving Magnet designation attracts and retains quality employees and ensures positive healthcare outcomes for consumers.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.
Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mirixa Corporation and the APhA Foundation Form Partnership
2. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
3. GenVault Corporation Launches GenTegra(TM) DNA
4. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
5. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
6. Alba Therapeutics Corporation Announces Promotions
7. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
8. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
9. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
10. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
11. Intact Medical Corporations Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
Breaking Biology Technology:
(Date:4/13/2017)... -- According to a new market research report "Consumer IAM ... and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global ... grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):